NSE: TATVA | BSE: 543321

Expensive Performer

Download real time

1400.00 9.20 (0.66%)

125.44% Gain from 52W Low

34,432 NSE+BSE Volume

NSE 19 Dec, 2025 3:31 PM (IST)

3,274.9

Market Cap

Above industry Median

Beta 1Year

Very Low volatility

Tatva Chintan Pharma Chem Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for TATVA, BSE:543321 Tatva Chintan Pharma Chem Ltd.

Tatva Chintan Pharma Chem Ltd.

15 Jul 2021

1400.00

0.66%

Tatva Chintan Pharma Chem Limited IPO Note

IPO Note: Tatva Chintan Pharma Chem ...

HDFC Securities

Tatva Chintan Pharma Chem Limited IPO Note Issue Open: July 16 July 20 2021 Price Band: Rs. 1073 1083 *Issue Size: 4,616,805 eq shares (Fresh Issue of 225 cr + Offer for sale of 275 cr) Issue Size: Rs.500.0 cr Reservation for: QIB Upto 50% eq sh Non Institutional atleast 15% eq sh Retail Upto 35% eq sh

Tatva Chintan Pharma has gained 63.32% in the last 1 Year

Tatva Chintan Pharma Chem Ltd.

15 Jul 2021

1400.00

0.66%

TATVA CHINTAN LIMITED

IPO Subscribe: Tatva Chintan Pharma Chem ...

Angel Broking

Incorporated in 1996, Tatva Chintan Pharma Chem Limited (Tatva Chintan) is a leading manufacturer of Structure Directing Agents (SDAs) and Phase Transfer Catalyst (PTCs) that have various applications in green chemistry. The company also manufactures Electrolyte Salts for super capacitor batteries (SCB) and Pharmaceutical & Agrochemical intermediates and other specialty chemicals (PASC). Its Product have

Tatva Chintan Pharma has gained 55.42% in the last 6 Months

Tatva Chintan Pharma Chem Ltd.

15 Jul 2021

1400.00

0.66%

TATVA CHINTAN PHARMA CHEM LTD.

IPO Note: Tatva Chintan Pharma Chem ...

Ventura

IPO NOTE

Tatva Chintan Pharma has gained 55.42% in the last 6 Months

Tatva Chintan Pharma Chem Ltd.

15 Jul 2021

1400.00

0.66%

Tatva Chintan Pharma Chem Ltd. IPO Note

IPO Note: Tatva Chintan Pharma Chem ...

Ashika Research

Public issue of 4,616,805 Equity shares of Face value Rs. Total Public 10 each, (Comprising of fresh issue of 2,077,562 Equity Shares* (Rs. 225 cr.) and Offer for Sale of 2,539,243 Equity Share Pre Issue (Nos. Cr.)...

Tatva Chintan Pharma Chem Ltd. is trading below its 30 day SMA of 1457.6

Tatva Chintan Pharma Chem Ltd.

15 Jul 2021

1400.00

0.66%

Tatva Chintan Pharma Chem : IPO

IPO Note: Tatva Chintan Pharma Chem ...

ICICI Securities Limited

Incorporated in 1996, Tatva Chintan is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). Apart from customers in India, the company also exports products to over 25 countries, including the US, China, Germany, Japan, South Africa, and the UK. As on March 31,...

Tatva Chintan Pharma has gained 63.32% in the last 1 Year

VOTE: Is Tatva Chintan Pharma Chem Ltd. worth buying?

52 Votes:

Buy 57.69%

Sell 23.08%

Hold 19.23%

RESEARCH REPORTS

Sell SEE REPORTS >

pdf

Sell SEE REPORTS >

pdf